Inactive Instrument

Press Releases Neos Therapeutics, Inc.

Equities

NEOS

US64052L1061

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

NEOS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements (form 8-K)	21-03-22	AQ
Neos Therapeutics : Aytu BioScience Announces Close of Merger with Neos Therapeutics	21-03-21	PU
Glass Lewis, a Leading Independent Proxy Advisory Firm, Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience	21-03-12	GL
Leading Independent Proxy Advisory Firm ISS Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience	21-03-10	GL
Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021	21-02-10	GL
NEOS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	21-02-08	AQ
NEOS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	21-01-11	AQ
Neos Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference	21-01-04	GL
NEOS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	20-12-30	AQ
NEOS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-12-11	AQ
NEOS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-12-10	AQ
Neos Therapeutics : Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company	20-12-10	AQ
NEOS THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-11-09	AQ
Neos Therapeutics: 3Q Earnings Snapshot	20-11-09	AQ
Neos Therapeutics : Reports Third Quarter 2020 Financial Results	20-11-09	AQ
Neos Therapeutics Reports Third Quarter 2020 Financial Results	20-11-09	GL
Neos Therapeutics : to Host Third Quarter 2020 Financial and Operating Results Conference Call on November 9th, 2020	20-11-02	AQ
Neos Therapeutics to Host Third Quarter 2020 Financial and Operating Results Conference Call on November 9th, 2020	20-11-02	GL
Neos Therapeutics : to Present at Cantor Virtual Global Healthcare Conference	20-09-09	AQ
Neos Therapeutics to Present at Cantor Virtual Global Healthcare Conference	20-09-09	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Neos Therapeutics, Inc.

Equities

NEOS

US64052L1061

Press Releases

Filters